Skip to content
PubMed This is a summary of 95 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 95 referenced papers

Top Authors

Eugen Trinka
Paracelsus Medical University
Enrique Carrazana
University of Hawaiʻi at Mānoa
Adrián L. Rabinowicz
Neurelis (United States)
Jacqueline A. French
New York University
Barry E. Gidal
University of Wisconsin–Madison
Michael R. Sperling
Thomas Jefferson University
Hal Blumenfeld
Yale University
William O. Tatum
Jacksonville College
Pavel Klein
Mid Atlantic Epilepsy and Sleep Center
Robert S. Fisher
Stanford University

Top Institutions

Ranked by publications Top 10 institutions
06

Neurelis (United States)

San Diego, United States

29 papers
07

University of Hawaiʻi at Mānoa

Honolulu, United States

28 papers
Contributors Enrique Carrazana

References

References (95)
  1. 1

    Resective epilepsy surgery for drug-resistant focal epilepsy: a review.

    Jobst BC, Cascino GD

    JAMA 2015; (313(3)):285-93 doi:10.1001/jama.2014.17426.

    PMID: 25602999
  2. 2

    Efficacy of low to moderate doses of oxcarbazepine in adult patients with newly diagnosed partial epilepsy.

    Zou XM, Chen JN, An DM, et al.

    Seizure 2015; (29()):81-5.

    PMID: 26076847
  3. 3

    Migraine aura symptoms: Duration, succession and temporal relationship to headache.

    Viana M, Linde M, Sances G, et al.

    Cephalalgia : an international journal of headache 2016; (36(5)):413-21 doi:10.1177/0333102415593089.

    PMID: 26156076
  4. 4

    The role of sleep electroencephalography in patients with new onset epilepsy.

    Delil S, Senel GB, Demiray DY, Yeni N

    Seizure 2015; (31()):80-3.

    PMID: 26362381
  5. 5

    Diagnosis of Epilepsy and Related Episodic Disorders.

    St Louis EK, Cascino GD

    Continuum (Minneapolis, Minn.) 2016; (22(1 Epilepsy)):15-37 doi:10.1212/CON.0000000000000284.

    PMID: 26844728
  6. 6

    Treatment of Convulsive Status Epilepticus.

    Grover EH, Nazzal Y, Hirsch LJ

    Current treatment options in neurology 2016; (18(3)):11 doi:10.1007/s11940-016-0394-5.

    PMID: 26920416
  7. 7

    Widespread changes in network activity allow non-invasive detection of mesial temporal lobe seizures.

    Lam AD, Zepeda R, Cole AJ, Cash SS

    Brain : a journal of neurology 2016; (139(Pt 10)):2679-2693 doi:10.1093/brain/aww198.

    PMID: 27474219
  8. 8

    Outcome of initial antiepileptic drug treatment in elderly patients with newly diagnosed epilepsy.

    Bruun E, Kälviäinen R, Keränen T

    Epilepsy research 2016; (127()):60-65 doi:10.1016/j.eplepsyres.2016.08.023.

    PMID: 27565412
  9. 9

    Discussing sudden unexpected death in epilepsy: Are we empowering our patients? A questionnaire survey.

    Keddie S, Angus-Leppan H, Parker T, et al.

    JRSM open 2016; (7(9)):2054270416654358 doi:10.1177/2054270416654358.

    PMID: 27688898
  10. 10

    Efficacy and Tolerability of Antiepileptic Drugs in Patients with Focal Epilepsy: Systematic Review and Network Meta-analyses.

    Campos MS, Ayres LR, Morelo MR, et al.

    Pharmacotherapy 2016; (36(12)):1255-1271 doi:10.1002/phar.1855.

    PMID: 27779771
  11. 11

    Epilepsy treatment in adults and adolescents: Expert opinion, 2016.

    Shih JJ, Whitlock JB, Chimato N, et al.

    Epilepsy & behavior : E&B 2017; (69()):186-222 doi:10.1016/j.yebeh.2016.11.018.

    PMID: 28237319
  12. 12

    Instruction manual for the ILAE 2017 operational classification of seizure types.

    Fisher RS, Cross JH, D'Souza C, et al.

    Epilepsia 2017; (58(4)):531-542 doi:10.1111/epi.13671.

    PMID: 28276064
  13. 13

    Most Children With Epilepsy Experience Postictal Phenomena, Often Preventing a Return to Normal Activities of Childhood.

    MacEachern SJ, D'Alfonso S, McDonald RJ, et al.

    Pediatric neurology 2017; (72()):42-50.e3 doi:10.1016/j.pediatrneurol.2017.03.002.

    PMID: 28483399
  14. 14

    Psychiatric side effects and antiepileptic drugs: Observations from prospective audits.

    Stephen LJ, Wishart A, Brodie MJ

    Epilepsy & behavior : E&B 2017; (71(Pt A)):73-78 doi:10.1016/j.yebeh.2017.04.003.

    PMID: 28551500
  15. 15

    Association of sleep with sudden unexpected death in epilepsy.

    Ali A, Wu S, Issa NP, et al.

    Epilepsy & behavior : E&B 2017; (76()):1-6 doi:10.1016/j.yebeh.2017.08.021.

    PMID: 28917499
  16. 16

    Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study.

    Chen Z, Brodie MJ, Liew D, Kwan P

    JAMA neurology 2018; (75(3)):279-286 doi:10.1001/jamaneurol.2017.3949.

    PMID: 29279892
  17. 17

    Lacosamide: A Review in Focal-Onset Seizures in Patients with Epilepsy.

    Hoy SM

    CNS drugs 2018; (32(5)):473-484 doi:10.1007/s40263-018-0523-7.

    PMID: 29785508
  18. 18

    Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis.

    Lattanzi S, Zaccara G, Giovannelli F, et al.

    Acta neurologica Scandinavica 2019; (139(1)):33-41 doi:10.1111/ane.13025.

    PMID: 30194755
  19. 19

    Putting it all together: Options for intractable epilepsy: An updated algorithm on the use of epilepsy surgery and neurostimulation.

    Benbadis SR, Geller E, Ryvlin P, et al.

    Epilepsy & behavior : E&B 2018; (88S()):33-38 doi:10.1016/j.yebeh.2018.05.030.

    PMID: 30241957
  20. 20

    Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

    Kanner AM, Ashman E, Gloss D, et al.

    Epilepsy currents 2018; (18(4)):260-268 doi:10.5698/1535-7597.18.4.260.

    PMID: 30254527
  21. 21

    Focal epilepsy without interictal spikes on scalp EEG: A common finding of uncertain significance.

    Basiri R, Shariatzadeh A, Wiebe S, Aghakhani Y

    Epilepsy research 2019; (150()):1-6 doi:10.1016/j.eplepsyres.2018.12.009.

    PMID: 30594882
  22. 22

    Validated outcome of treatment changes according to International League Against Epilepsy criteria in adults with drug-resistant focal epilepsy.

    Mula M, Zaccara G, Galimberti CA, et al.

    Epilepsia 2019; (60(6)):1114-1123 doi:10.1111/epi.14685.

    PMID: 30866058
  23. 23

    7T MRI in epilepsy patients with previously normal clinical MRI exams compared against healthy controls.

    Feldman RE, Delman BN, Pawha PS, et al.

    PloS one 2019; (14(3)):e0213642 doi:10.1371/journal.pone.0213642.

    PMID: 30889199
  24. 24

    Signs and symptoms of the postictal period in epilepsy: A systematic review and meta-analysis.

    Subota A, Khan S, Josephson CB, et al.

    Epilepsy & behavior : E&B 2019; (94()):243-251 doi:10.1016/j.yebeh.2019.03.014.

    PMID: 30978637
  25. 25

    Comparison and Selection of Current Implantable Anti-Epileptic Devices.

    Wong S, Mani R, Danish S

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2019; (16(2)):369-380 doi:10.1007/s13311-019-00727-2.

    PMID: 31062294
  26. 26

    Epilepsy surgery.

    Rugg-Gunn F, Miserocchi A, McEvoy A

    Practical neurology 2020; (20(1)):4-14 doi:10.1136/practneurol-2019-002192.

    PMID: 31420415
  27. 27

    Oxcarbazepine add-on for drug-resistant focal epilepsy.

    Bresnahan R, Atim-Oluk M, Marson AG

    The Cochrane database of systematic reviews 2020; (3()):CD012433 doi:10.1002/14651858.CD012433.pub2.

    PMID: 32129501
  28. 28

    Efficacy and safety of perampanel monotherapy in patients with focal-onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open-label Study 342 (FREEDOM Study).

    Yamamoto T, Lim SC, Ninomiya H, et al.

    Epilepsia open 2020; (5(2)):274-284 doi:10.1002/epi4.12398.

    PMID: 32524053
  29. 29

    Hyperkinetic Seizures with Ictal Fear as Localizing Ictal Signs in MRI-Negative Medial Frontal Lobe Epilepsy.

    Cloppenborg T, Albers K, Kalbhenn T, et al.

    Neuropediatrics 2021; (52(1)):44-47 doi:10.1055/s-0040-1715630.

    PMID: 32842161
  30. 30

    The Sensitivity of Scalp EEG at Detecting Seizures-A Simultaneous Scalp and Stereo EEG Study.

    Casale MJ, Marcuse LV, Young JJ, et al.

    Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 2022; (39(1)):78-84 doi:10.1097/WNP.0000000000000739.

    PMID: 32925173
  31. 31

    Experiential seizures related to the hippocampal-parahippocampal spatial representation system.

    Revdal E, Arntsen V, Doan TP, et al.

    Epilepsy & behavior reports 2020; (14()):100386 doi:10.1016/j.ebr.2020.100386.

    PMID: 32995740
  32. 32

    Can We Prevent Sudden Unexpected Death in Epilepsy (SUDEP)?

    Bhasin H, Sharma S, Ramachandrannair R

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2021; (48(4)):464-468 doi:10.1017/cjn.2020.221.

    PMID: 33023683
  33. 33

    Diagnostic yield of seizure recordings and neuroimaging in patients with focal epilepsy without interictal epileptiform discharges.

    Suzuki M, Jin K, Kitazawa Y, et al.

    Epilepsy & behavior : E&B 2020; (112()):107468 doi:10.1016/j.yebeh.2020.107468.

    PMID: 33181891
  34. 34

    [SUDEP in brief - knowledge and practice recommendations on sudden unexpected death in epilepsy].

    Surges R, Conrad S, Hamer HM, et al.

    Der Nervenarzt 2021; (92(8)):809-815 doi:10.1007/s00115-021-01075-3.

    PMID: 33591415
  35. 35

    The SANTÉ study at 10 years of follow-up: Effectiveness, safety, and sudden unexpected death in epilepsy.

    Salanova V, Sperling MR, Gross RE, et al.

    Epilepsia 2021; (62(6)):1306-1317 doi:10.1111/epi.16895.

    PMID: 33830503
  36. 36

    Response to first antiseizure medication in patients diagnosed with epilepsy.

    Hersi H, Saarinen JT, Raitanen J, Peltola J

    Acta neurologica Scandinavica 2021; (144(1)):67-75 doi:10.1111/ane.13426.

    PMID: 33835491
  37. 37

    Phase-amplitude coupling of ripple activities during seizure evolution with theta phase.

    Hashimoto H, Khoo HM, Yanagisawa T, et al.

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2021; (132(6)):1243-1253 doi:10.1016/j.clinph.2021.03.007.

    PMID: 33867253
  38. 38

    Sudden Unexpected Death in Epilepsy: A Personalized Prediction Tool.

    Jha A, Oh C, Hesdorffer D, et al.

    Neurology 2021; (96(21)):e2627-e2638 doi:10.1212/WNL.0000000000011849.

    PMID: 33910939
  39. 39

    Electroclinical markers to differentiate between focal and generalized epilepsies.

    Raga S, Rheims S, Specchio N, Wilmshurst JM

    Epileptic disorders : international epilepsy journal with videotape 2021; (23(3)):437-458 doi:10.1684/epd.2021.1291.

    PMID: 34106053
  40. 40

    In the pursuit of the epileptogenic zone - listen carefully and look deeply.

    Nascimento FA, Srinivasan VM, Sheth SA, Gavvala JR

    Epileptic disorders : international epilepsy journal with videotape 2021; (23(4)):667-673 doi:10.1684/epd.2021.1297.

    PMID: 34184989
  41. 41

    Clinical Management of Drug Resistant Epilepsy: A Review on Current Strategies.

    Guery D, Rheims S

    Neuropsychiatric disease and treatment 2021; (17()):2229-2242 doi:10.2147/NDT.S256699.

    PMID: 34285484
  42. 42

    Arousal and Consciousness in Focal Seizures.

    Blumenfeld H

    Epilepsy currents 2021; (21(5)):353-359 doi:10.1177/15357597211029507.

    PMID: 34924835
  43. 43

    Diagnostic value of MRI in the presurgical evaluation of patients with epilepsy: influence of field strength and sequence selection: a systematic review and meta-analysis from the E-PILEPSY Consortium.

    Rados M, Mouthaan B, Barsi P, et al.

    Epileptic disorders : international epilepsy journal with videotape 2022; (24(2)):323-342 doi:10.1684/epd.2021.1399.

    PMID: 34961746
  44. 44

    Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.

    Nevitt SJ, Sudell M, Cividini S, et al.

    The Cochrane database of systematic reviews 2022; (4()):CD011412 doi:10.1002/14651858.CD011412.pub4.

    PMID: 35363878
  45. 45

    Antiseizure Medications for Adults With Epilepsy: A Review.

    Kanner AM, Bicchi MM

    JAMA 2022; (327(13)):1269-1281 doi:10.1001/jama.2022.3880.

    PMID: 35380580
  46. 46

    Surgical Treatments for Epilepsy.

    Culler GW, Jobst BC

    Continuum (Minneapolis, Minn.) 2022; (28(2)):536-558 doi:10.1212/CON.0000000000001106.

    PMID: 35393969
  47. 47

    Auditory verbal hallucinations as ictal phenomena in a patient with drug-resistant epilepsy.

    Perez JT, Burneo JG, Macdougall K, et al.

    Clinical neurology and neurosurgery 2022; (216()):107223 doi:10.1016/j.clineuro.2022.107223.

    PMID: 35413637
  48. 48

    Seizure semiology: ILAE glossary of terms and their significance.

    Beniczky S, Tatum WO, Blumenfeld H, et al.

    Epileptic disorders : international epilepsy journal with videotape 2022; (24(3)):447-495 doi:10.1684/epd.2022.1430.

    PMID: 35770761
  49. 49

    Diagnostic Puzzle of Acute Ischemic Stroke Mimics - Seizure Versus Post-Stroke Recrudescence: A Case Report.

    Akintomide FA, Hosseini R, Candale-Radu C, Khan K

    The American journal of case reports 2022; (23()):e936826 doi:10.12659/AJCR.936826.

    PMID: 35773951
  50. 50

    "Temporal" intermittent rhythmic delta activity: the true localizing nature of TIRDA

    Freund BE, Mheir-Al-Saadi Z, Brinkmann BH, Tatum WO

    Epileptic disorders : international epilepsy journal with videotape 2022; (24(5)):947-951 doi:10.1684/epd.2022.1459.

    PMID: 35816099
  51. 51

    Temporal encephalocele: a rare but treatable cause of temporal lobe epilepsy

    Jagtap SA, Kurwale N, Patil S, et al.

    Epileptic disorders : international epilepsy journal with videotape 2022; (24(6)):1073-1080 doi:10.1684/epd.2022.1487.

    PMID: 36153932
  52. 52

    Opportunities for Community Pharmacists to Counsel Patients With Epilepsy and Seizure Clusters to Overcome Barriers and Foster Appropriate Treatment.

    Gidal B, Welty T, Cokley J, et al.

    Journal of pharmacy practice 2024; (37(1)):190-197 doi:10.1177/08971900221126570.

    PMID: 36193947
  53. 53

    Migraine aura-like symptoms at onset of stroke and stroke-like symptoms in migraine with aura.

    Scutelnic A, Kreis LA, Beyeler M, et al.

    Frontiers in neurology 2022; (13()):1004058 doi:10.3389/fneur.2022.1004058.

    PMID: 36203991
  54. 54

    Rescue Treatments for Seizure Clusters.

    Kotloski RJ, Gidal BE

    Neurologic clinics 2022; (40(4)):927-937 doi:10.1016/j.ncl.2022.03.016.

    PMID: 36270699
  55. 55

    Implications of Seizure-Cluster Treatment on Healthcare Utilization: Use of Approved Rescue Medications.

    Rabinowicz AL, Faught E, Cook DF, Carrazana E

    Neuropsychiatric disease and treatment 2022; (18()):2431-2441 doi:10.2147/NDT.S376104.

    PMID: 36325434
  56. 56

    Response to subsequent antiseizure medications after first antiseizure medication failure in newly diagnosed epilepsy.

    Hersi H, Saarinen JT, Raitanen J, Peltola J

    Frontiers in neurology 2022; (13()):1042168 doi:10.3389/fneur.2022.1042168.

    PMID: 36438960
  57. 57

    Symptoms and patterns of symptom propagation in incipient ischemic stroke and migraine aura.

    Scutelnic A, Bracher J, Kreis LA, et al.

    Frontiers in human neuroscience 2022; (16()):1077737 doi:10.3389/fnhum.2022.1077737.

    PMID: 36741781
  58. 58

    Focal epilepsies: Update on diagnosis and classification.

    Nascimento FA, Friedman D, Peters JM, et al.

    Epileptic disorders : international epilepsy journal with videotape 2023; (25(1)):1-17 doi:10.1002/epd2.20045.

    PMID: 36938903
  59. 59

    SUDEP counseling: Where do we stand?

    Whitney R, Jones KC, Sharma S, RamachandranNair R

    Epilepsia 2023; (64(6)):1424-1431 doi:10.1111/epi.17617.

    PMID: 37039574
  60. 60

    Acute Abortive Therapies for Seizure Clusters in Long-Term Care.

    Ramsay RE, Becker DA, Vazquez B, et al.

    Journal of the American Medical Directors Association 2023; (24(8)):1225-1232 doi:10.1016/j.jamda.2023.04.015.

    PMID: 37253432
  61. 61

    [Cingulate seizure as a clinical manifestation of anti-myelin oligodendrocyte glycoprotein antibody-positive cerebral cortical encephalitis of two cases].

    Tanaka T, Togo M, Okayama K, et al.

    Rinsho shinkeigaku = Clinical neurology 2023; (63(7)):441-449 doi:10.5692/clinicalneurol.cn-001724.

    PMID: 37394493
  62. 62

    Localizing and lateralizing value of auditory phenomena in seizures.

    Cossette-Roberge H, Li J, Citherlet D, Nguyen DK

    Epilepsy & behavior : E&B 2023; (145()):109327 doi:10.1016/j.yebeh.2023.109327.

    PMID: 37422934
  63. 63

    A new strategy for treating drug-resistant focal aware seizures: thalamic specific nuclei deep brain stimulation. Illustrative case.

    Vilela-Filho O, Silva-Filho HF, Goulart LC, et al.

    Journal of neurosurgery. Case lessons 2023; (6(8)).

    PMID: 37728299
  64. 64

    Focal aware somatosensory seizures with paresis as a complication of surgery for chronic subdural hematoma.

    Ishida S, Nitta N, Yoshida K

    Epilepsy & behavior reports 2023; (24()):100621 doi:10.1016/j.ebr.2023.100621.

    PMID: 37790214
  65. 65

    Measuring quality and safety of epilepsy monitoring units in Brazil: Adoption of quality indicators.

    de Albuquerque LCP, Torres CM, Batista CEA, et al.

    Seizure 2024; (115()):68-74 doi:10.1016/j.seizure.2023.12.021.

    PMID: 38218112
  66. 66

    Benzodiazepines for the Treatment of Seizure Clusters.

    Penovich PE, Rao VR, Long L, et al.

    CNS drugs 2024; (38(2)):125-140 doi:10.1007/s40263-023-01060-1.

    PMID: 38358613
  67. 67

    The role of neuromodulation in the management of drug-resistant epilepsy.

    Salama H, Salama A, Oscher L, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2024; (45(9)):4243-4268 doi:10.1007/s10072-024-07513-9.

    PMID: 38642321
  68. 68

    Outpatient management of prolonged seizures and seizure clusters to prevent progression to a higher-level emergency: Consensus recommendations of an expert working group.

    Pina-Garza JE, Chez M, Cloyd J, et al.

    Epileptic disorders : international epilepsy journal with videotape 2024; (26(4)):484-497 doi:10.1002/epd2.20243.

    PMID: 38813941
  69. 69

    Therapeutic strategies during cenobamate treatment initiation: Delphi panel recommendations.

    Steinhoff BJ, Ben-Menachem E, Klein P, et al.

    Therapeutic advances in neurological disorders 2024; (17()):17562864241256733 doi:10.1177/17562864241256733.

    PMID: 38883228
  70. 70

    Anti-LGI-1 Limbic Encephalitis and Autoimmune Epilepsy Following a Third Dose of COVID-19 Vaccination: A Case Report.

    Mullan G, Kinney M

    The Neurohospitalist 2024; (14(3)):332-335 doi:10.1177/19418744241234100.

    PMID: 38895001
  71. 71

    Short-Term Impact of Seizures and Mitigation Opportunities.

    Glauser T, Becker DA, Long L, et al.

    Current neurology and neuroscience reports 2024; (24(8)):303-314 doi:10.1007/s11910-024-01350-1.

    PMID: 38940995
  72. 72

    Network signatures define consciousness state during focal seizures.

    Doss DJ, Johnson GW, Makhoul GS, et al.

    Epilepsia 2024; (65(9)):2686-2699 doi:10.1111/epi.18074.

    PMID: 39056406
  73. 73

    Antiseizure Medications and Sudden Unexpected Death in Epilepsy: An Updated Review.

    Bosch AT, Sander JW, Thijs RD

    CNS drugs 2024; (38(10)):807-817 doi:10.1007/s40263-024-01112-0.

    PMID: 39112912
  74. 74

    Treatment of prolonged seizure with diazepam nasal spray: An exploratory post hoc cohort analysis.

    Jarrar R, Stern JM, Becker DA, et al.

    Epilepsy & behavior : E&B 2024; (159()):109987 doi:10.1016/j.yebeh.2024.109987.

    PMID: 39181105
  75. 75

    The Adverse Effects of Commonly Prescribed Antiseizure Medications in Adults With Newly Diagnosed Focal Epilepsy.

    Barnard SN, Chen Z, Kanner AM, et al.

    Neurology 2024; (103(7)):e209821 doi:10.1212/WNL.0000000000209821.

    PMID: 39270150
  76. 76

    Ictal Involvement of the Pulvinar and the Anterior Nucleus of the Thalamus in Patients With Refractory Epilepsy.

    McGinn R, Von Stein EL, Datta A, et al.

    Neurology 2024; (103(11)):e210039 doi:10.1212/WNL.0000000000210039.

    PMID: 39531602
  77. 77

    First Seizures, Acute Repetitive Seizures, and Status Epilepticus.

    Vossler DG

    Continuum (Minneapolis, Minn.) 2025; (31(1)):95-124 doi:10.1212/CON.0000000000001530.

    PMID: 39899098
  78. 78

    Seizure Detection Devices.

    Baumgartner C, Baumgartner J, Lang C, et al.

    Journal of clinical medicine 2025; (14(3)) doi:10.3390/jcm14030863.

    PMID: 39941534
  79. 79

    Harmonization of MRI sequences across ERN EpiCARE centers.

    Adler S, D'Arco F, Mankad K, et al.

    Epilepsia open 2025; (10(2)):587-592 doi:10.1002/epi4.13115.

    PMID: 39943698
  80. 80

    Updated classification of epileptic seizures: Position paper of the International League Against Epilepsy.

    Beniczky S, Trinka E, Wirrell E, et al.

    Epilepsia 2025; (66(6)):1804-1823 doi:10.1111/epi.18338.

    PMID: 40264351
  81. 81

    Early Introduction of Cenobamate in Uncontrolled Focal Epilepsy: Insights from a Structured Controversy.

    Labate A, Liguori C, Tartara E, et al.

    Neurology and therapy 2025; (14(4)):1671-1684 doi:10.1007/s40120-025-00781-3.

    PMID: 40586971
  82. 82

    Mapping Postictal Aphasia through Signal Complexity: A Stereo-Electroencephalography Study.

    Bratu IF, Bénar CG, Villalon SM, et al.

    Annals of neurology 2025; (98(5)):1080-1095 doi:10.1002/ana.27307.

    PMID: 40646712
  83. 83

    Clinical features, including atypical symptoms, associated with acute cerebral ischaemia on DWI-MRI in suspected TIA and minor stroke.

    Gallogly PC, Hassan J, Lee C, et al.

    International journal of stroke : official journal of the International Stroke Society 2026; (21(3)):353-361 doi:10.1177/17474930251368895.

    PMID: 40778605
  84. 84

    Treatment Response to Antiseizure Medications in People With Newly Diagnosed Focal Epilepsy.

    Barnard SN, Chen Z, Holmes M, et al.

    JAMA neurology 2025; (82(10)):1022-1030 doi:10.1001/jamaneurol.2025.2949.

    PMID: 40853673
  85. 85

    Postictal status and clinical variables in adults with epilepsy.

    Agostinho CF, Tedrus GMAS

    Arquivos de neuro-psiquiatria 2025; (83(9)):1-6 doi:10.1055/s-0045-1811625.

    PMID: 40921409
  86. 86

    Lateral septal inhibition of nucleus basalis through direct and indirect pathways in focal limbic seizures.

    Liu J, Sieu LA, Shi I, et al.

    bioRxiv : the preprint server for biology 2025; doi:10.1101/2025.09.17.676820.

    PMID: 41000632
  87. 87

    Efficacy and safety of perampanel monotherapy in Chinese children with newly diagnosed focal epilepsy: a single-center prospective study.

    Hong Y, Lu Y, Chen H, Liu Z

    Translational pediatrics 2025; (14(10)):2758-2764 doi:10.21037/tp-2025-396.

    PMID: 41216460
  88. 88

    Multi-unit activity and high-gamma patterns dissociate in the seizure onset zone during focal to bilateral tonic-clonic seizures.

    Gorska-Klimowska U, Mat B, Denis C, et al.

    medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.11.03.25339320.

    PMID: 41282923
  89. 89

    Human Mediodorsal Thalamus in Seizure Propagation.

    Marais O, Lozano C, Risman A, et al.

    bioRxiv : the preprint server for biology 2025; doi:10.64898/2025.12.01.691640.

    PMID: 41573911
  90. 90

    Deep characterization of refractory epilepsy due to mild malformation of cortical development with oligodendroglial hyperplasia (MOGHE) and insights into the role of invasive monitoring.

    Khoury J, Blümcke I, Busch RM, et al.

    Epilepsia 2026; (67(5)):2227-2240 doi:10.1002/epi.70118.

    PMID: 41627170
  91. 91

    Current perspectives in sudden unexpected death in epilepsy (SUDEP): epidemiology, research approaches and pathways to prevention.

    Mann C, Schubert-Bast S, Rosenow F, Strzelczyk A

    Neurological research and practice 2026; (8(1)).

    PMID: 41877292
  92. 92

    Thalamocortical network dynamics in focal epilepsy: SEEG investigation.

    Nester EM, Jayaram MA, Umesh T, et al.

    bioRxiv : the preprint server for biology 2026; doi:10.64898/2026.03.05.709626.

    PMID: 41959414
  93. 93

    Postictal Todd's Paralysis Mimicking Acute Ischemic Stroke in Medullary Melanocytoma: A Multimodal Diagnostic Challenge.

    Ali S, Memari K, Lazo LP, et al.

    Cureus 2026; (18(3)):e104991 doi:10.7759/cureus.104991.

    PMID: 41970113
  94. 94

    Navigating safety and sudden unexpected death in epilepsy (SUDEP) discussions in adolescents with epilepsy: short-term outcomes of a structured counselling intervention.

    Kumar S, Elwadhi A, Chowdhury SR, et al.

    Epilepsy & behavior : E&B 2026; (182()):111134 doi:10.1016/j.yebeh.2026.111134.

    PMID: 42208388
  95. 95

    Comparison of volume- and surface-based magnetic resonance imaging morphometry algorithms in the detection of focal cortical dysplasia.

    Bücheler L, Reisert M, Demerath T, et al.

    Epilepsia 2026; doi:10.1002/epi.70326.

    PMID: 42233975